Related Experiment Videos
Psychosocial aspects of diabetes with an emphasis on depression
1Cedars-Sinai Medical Group, 250 N. Robertson Boulevard, Beverly Hills, CA 90211, USA. harrism@csmns.org
Insights
Depression is three times more common in individuals with diabetes, leading to poorer glycemic control and increased complications. Treating depression in diabetics improves blood sugar management and overall quality of life.
Area of Science:
- Endocrinology
- Psychiatry
- Metabolic Diseases
Background:
- Chronic diseases are linked to mood disorders.
- Diabetes imposes significant self-management burdens, including glucose monitoring and insulin therapy.
- Depression prevalence is notably higher in diabetic populations compared to the general population.
Observation:
- Depression is approximately three times more prevalent in individuals with diabetes.
- Diabetic patients experiencing depression exhibit poorer glycemic control.
- Depression in diabetes is associated with an increased risk of microvascular and macrovascular complications.
Findings:
- Treatment for depression in diabetic patients, whether pharmacologic or behavioral, improves glycemic control.
- Intervention for depression enhances the quality of life for individuals with diabetes.
- Common antidepressant side effects relevant to the diabetic state are discussed.
Implications:
- Further research is needed to explore the causal link between depression and diabetes onset.
- Longitudinal studies should investigate the relationship between depression and diabetic complication rates.
- Early intervention for depression and development of coping mechanisms may impact the natural history of diabetes.
Abstract:
Any chronic disease is associated with an increased prevalence of mood disorders and depression. Diabetes is unique in that it places the burdens of invasive blood glucose monitoring, regimentation of diet and exercise, and often multiple daily insulin injections into the hands of the individual. Therefore, it is not surprising that depression may be three times more prevalent in the diabetic population when compared with nondiabetic individuals. Depressed patients with diabetes have been shown to have poorer glycemic control and a higher incidence of microvascular and macrovascular complications. Treatment of the depression associated with diabetes with either pharmacologic therapy or behavioral intervention has been shown to result in improved glycemic control and quality of life. Specific side effects of commonly used antidepressant medications, which have particular bearing on the diabetic state, are discussed. Future research into the causal relationship of depression to the onset on diabetes, longitudinal studies looking at depression and the rate of occurrence of diabetic complications, and the impact of the early development of healthy coping mechanisms and the treatment of depression on the natural history of diabetes are needed.